"It’s a privilege to join Compass Pathways at such a pivotal moment, and to help advance innovation in mental health care for patients living with difficult-to-treat mental health conditions who desperately need new options."

Dr Michael Gold

Chief Research and Development Officer

Michael is a passionate and highly effective pharmaceutical executive, bringing more than 25 years of experience across all aspects of drug development in neuroscience to Compass. Before joining Compass, he led the Neuroscience Therapeutic Area at AbbVie, including the integration of Allergan

Michael has extensive therapeutic experience in neurological disorders and psychiatric disorders, including depression. He has worked extensively with small molecules, biologicals, drug-device combinations, diagnostics and various types of biomarkers. He has significant experience in all segments of the pharmaceutical/biotechnology sector, including large, small, specialty, start-up and CRO companies. Michael is a highly respected leader in neuroscience drug development and sits on multiple advisory boards and served as the industry representative for advisory committees of the FDA’s Office of Neuroscience. Dr. Gold completed his Neurology residency at the Albert Einstein College of Medicine (NYC) , a fellowship in Behavioral Neurology at the University of Florida and then on a faculty position af the University of South Florida prior to joining industry.

"It’s a privilege to join Compass Pathways at such a pivotal moment, and to help advance innovation in mental health care for patients living with difficult-to-treat mental health conditions who desperately need new options."
Back to Our Team